Notice of Development of Set 26 Toxicological Profiles, 4147-4148 [2013-00991]
Download as PDF
<![CDATA[
4147
Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average burden
per response
(in hours)
Total burden
hours
Adult Viral Hepatitis Prevention Coordinators ...............................................
State and local health departments ...............................................................
Community-based organizations ...................................................................
National organizations ...................................................................................
Correctional facilities ......................................................................................
Healthcare providers ......................................................................................
4
16
12
12
12
12
1
1
1
1
1
1
1.5
.75
.5
.5
.5
.5
6
12
6
6
6
6
Total ........................................................................................................
........................
........................
..........................
42
OASH specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Deputy Information Collection Clearance
Officer.
[FR Doc. 2013–01022 Filed 1–17–13; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice of meeting.
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public. Preregistration is required for both public
attendance and comment. Individuals
who wish to attend the meeting and/or
participate in the public comment
session should register at https://
www.hhs.gov/nvpo/nvac, email
nvpo@hhs.gov, or call 202–690–5566
and provide name, organization, and
email address.
DATES: The meeting will be held on
February 5–6, 2013. The meeting times
and agenda will be posted on the NVAC
mstockstill on DSK4VPTVN1PROD with
SUMMARY:
VerDate Mar<15>2010
16:52 Jan 17, 2013
Jkt 229001
Web site at https://www.hhs.gov/nvpo/
nvac as soon as they become available.
ADDRESSES: U.S. Department of Health
and Human Services, Hubert H.
Humphrey Building, Room 800, 200
Independence Avenue SW.,
Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; Fax: (202) 690–
4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
Among the topics to be discussed at
the NVAC meeting include the
Affordable Care Act, pertussis, polio
eradication, global vaccination, and
HPV vaccine coverage. The meeting
agenda will be posted on the NVAC
Web site: https://www.hhs.gov/nvpo/
nvac prior to the meeting.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
National Vaccine Program Office at the
address/phone listed above at least one
week prior to the meeting. Members of
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
the public will have the opportunity to
provide comments at the NVAC meeting
during the public comment periods on
the agenda. Individuals who would like
to submit written statements should
email or fax their comments to the
National Vaccine Program Office at least
five business days prior to the meeting.
Dated: January 10, 2013.
Bruce Gellin,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2013–00950 Filed 1–17–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[ATSDR–277]
Notice of Development of Set 26
Toxicological Profiles
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
AGENCY:
ACTION:
Notice.
This notice announces the
development of Set 26 Toxicological
Profiles, which will consist of three
updated profiles and two new profiles.
Draft for Public Comment versions of
these profiles will be available to the
public on or about October 17, 2013.
Electronic access to these documents
will be available at the ATSDR Web site:
https://www.atsdr.cdc.gov/toxprofiles/
index.asp.
SUMMARY:
Set 26 Toxicological Profiles
The following toxicological profiles
are now being developed:
E:\FR\FM\18JAN1.SGM
18JAN1
4148
Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices
Name
CAS
1. Trichloroethylene (UPDATE) ..
2. Tetrachloroethylene (UPDATE).
3. Hydrogen sulfide/Carbonyl
sulfide (UPDATE).
4. Glutaraldehyde (NEW) ...........
5. Parathion (NEW) ....................
79–01–6
127–18–4
7783–06–4
463–58–1
111–30–8
56–38–2
Clifton Road NE., Mail Stop F–57,
Atlanta, GA 30333, telephone 770–488–
3313.
Dated: January 11, 2013.
Ken Rose,
Director, Office of Policy Planning and
Evaluation, National Center for
Environmental Health.
[FR Doc. 2013–00991 Filed 1–17–13; 8:45 am]
mstockstill on DSK4VPTVN1PROD with
SUPPLEMENTARY INFORMATION:
The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) (42
U.S.C. 9601 et seq.) amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) (42
U.S.C. 9601 et seq.) by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) with regard to hazardous
substances that are most commonly
found at facilities on the CERCLA
National Priorities List (NPL). Among
these statutory requirements is a
mandate for the Administrator of
ATSDR to prepare toxicological profiles
for each substance included on the
Priority List of Hazardous Substances
(www.atsdr.cdc.gov/SPL). This list
names 275 hazardous substances that
pose the most significant potential
threat to human health as determined by
ATSDR and EPA. The availability of the
revised list of the 275 priority
substances was announced in the
Federal Register on November 3, 2011
(76 FR 68193). For prior versions of the
list of substances, see Federal Register
notices dated April 17, 1987 (52 FR
12866); October 20, 1988 (53 FR 41280);
October 26, 1989 (54 FR 43619); October
17, 1990 (55 FR 42067); October 17,
1991 (56 FR 52166); October 28, 1992
(57 FR 48801); February 28, 1994 (59 FR
9486); April 29, 1996 (61 FR 18744;
November 17, 1997 (62 FR 61332);
October 21, 1999 (64 FR 56792); October
25, 2001 (66 FR 54014); November 7,
2003 (68 FR 63098); December 7, 2005
(70FR 70284): and March 6, 2008 (73 FR
12178).
Notice of the availability of drafts of
these five toxicological profiles for
public review and comment will be
published in the Federal Register on or
about October 17, 2013, with notice of
a 90-day public comment period for
each profile, starting from the actual
release date. Following the close of the
comment period, chemical-specific
comments will be addressed, and,
where appropriate, changes will be
incorporated into each profile.
FOR FURTHER INFORMATION CONTACT:
Commander Jessilynn B. Taylor,
Division of Toxicology and Human
Health Sciences, Agency for Toxic
Substances and Disease Registry, 1600
VerDate Mar<15>2010
16:52 Jan 17, 2013
Jkt 229001
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0600]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis and Nontuberculous
Mycobacteria Drug Susceptibility
Testing OMB #0920–0600 (exp. 5/31/
2013),—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Background and Brief Description
As part of the continuing effort to
support domestic public health
objectives for treatment of tuberculosis
(TB), prevention of multi-drug
resistance, and surveillance programs,
CDC is requesting approval from the
Office of Management and Budget to
continue data collection from
participants in the Model Performance
Evaluation Program for Mycobacterium
tuberculosis and Non-tuberculous
Mycobacterium Drug Susceptibility
Testing. This revision request includes
(a) Changing the title of the data
collection to ‘‘CDC Model Performance
Evaluation (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility
Testing’’ to reflect that nontuberculous
mycobacteria are no longer included in
the test package; (b) replacement of
Laboratory Enrollment Form with a
Participant Biosafety Compliance Letter
of Agreement; (c) revision of the Preshipment Email; (d) addition of
Instructions to Participants Letter; (e)
revision of the MPEP M. tuberculosis
Results Worksheet; (f) entering survey
results online using a modified data
collection instrument; (g) modification
of Reminder Email; (h) modification of
Reminder Telephone Script; and (i)
modification of the Aggregate Report
Letter.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium tuberculosis and
Non-tuberculous Mycobacterium Drug
Susceptibility Testing is used to monitor
and evaluate performance and practices
among national laboratories performing
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
By providing an evaluation program
to assess the ability of the laboratories
to test for drug resistant M. tuberculosis
strains, laboratories also have a selfassessment tool to aid in optimizing
their skills in susceptibility testing. The
information obtained from the
laboratories on susceptibility practices
and procedures is used to establish
variables related to good performance,
assessing training needs, and aid with
the development of practice standards.
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 78, Number 13 (Friday, January 18, 2013)]
[Notices]
[Pages 4147-4148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00991]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[ATSDR-277]
Notice of Development of Set 26 Toxicological Profiles
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the development of Set 26 Toxicological
Profiles, which will consist of three updated profiles and two new
profiles. Draft for Public Comment versions of these profiles will be
available to the public on or about October 17, 2013. Electronic access
to these documents will be available at the ATSDR Web site: https://www.atsdr.cdc.gov/toxprofiles/index.asp.
Set 26 Toxicological Profiles
The following toxicological profiles are now being developed:
[[Page 4148]]
------------------------------------------------------------------------
Name CAS
------------------------------------------------------------------------
1. Trichloroethylene (UPDATE)............. 79-01-6
2. Tetrachloroethylene (UPDATE)........... 127-18-4
3. Hydrogen sulfide/Carbonyl sulfide 7783-06-4
(UPDATE). 463-58-1
4. Glutaraldehyde (NEW)................... 111-30-8
5. Parathion (NEW)........................ 56-38-2
------------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization
Act of 1986 (SARA) (42 U.S.C. 9601 et seq.) amended the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA
or Superfund) (42 U.S.C. 9601 et seq.) by establishing certain
requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA) with regard to hazardous substances that are most commonly found
at facilities on the CERCLA National Priorities List (NPL). Among these
statutory requirements is a mandate for the Administrator of ATSDR to
prepare toxicological profiles for each substance included on the
Priority List of Hazardous Substances (www.atsdr.cdc.gov/SPL). This
list names 275 hazardous substances that pose the most significant
potential threat to human health as determined by ATSDR and EPA. The
availability of the revised list of the 275 priority substances was
announced in the Federal Register on November 3, 2011 (76 FR 68193).
For prior versions of the list of substances, see Federal Register
notices dated April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR
41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR 42067);
October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801);
February 28, 1994 (59 FR 9486); April 29, 1996 (61 FR 18744; November
17, 1997 (62 FR 61332); October 21, 1999 (64 FR 56792); October 25,
2001 (66 FR 54014); November 7, 2003 (68 FR 63098); December 7, 2005
(70FR 70284): and March 6, 2008 (73 FR 12178).
Notice of the availability of drafts of these five toxicological
profiles for public review and comment will be published in the Federal
Register on or about October 17, 2013, with notice of a 90-day public
comment period for each profile, starting from the actual release date.
Following the close of the comment period, chemical-specific comments
will be addressed, and, where appropriate, changes will be incorporated
into each profile.
FOR FURTHER INFORMATION CONTACT: Commander Jessilynn B. Taylor,
Division of Toxicology and Human Health Sciences, Agency for Toxic
Substances and Disease Registry, 1600 Clifton Road NE., Mail Stop F-57,
Atlanta, GA 30333, telephone 770-488-3313.
Dated: January 11, 2013.
Ken Rose,
Director, Office of Policy Planning and Evaluation, National Center for
Environmental Health.
[FR Doc. 2013-00991 Filed 1-17-13; 8:45 am]
BILLING CODE P
